Abstract

BackgroundThe significance of long non-coding RNAs (lncRNAs) in mediating oxidative stress of cancers has been implicated recently. This study proposed a potential therapeutic target lncRNA growth arrest-specific transcript 5 (GAS5) for melanoma, due to its crucial role in oxidative stress and apoptosis of melanoma cells by regulating the enhancer of zeste homolog 2 (EZH2)-mediated CDKN1C expression.MethodsThe lncRNA GAS5 expression pattern was examined in melanoma tissues and cells. The correlation of lncRNA GAS5, EZH2, and CDKN1C with survival rate of melanoma patients was analyzed. In melanoma cell lines, lncRNA GAS5 expression was overexpressed or knocked down to clarify its effects on cell viability, apoptosis, and oxidative stress. The interaction between lncRNA GAS5 and EZH2 was examined by RIP and RNA pull-down assays followed by verification of the target relationship between EZH2 and CDKN1C.ResultsHigh expression of EZH2 and poor expression of lncRNA GAS5 and CDKN1C was observed in melanoma tissues and found to be correlated with the reduction in survival expectancy of melanoma patients. Overexpression of lncRNA GAS5 or CDKN1C or EZH2 knockdown could inhibit cell viability but enhance melanoma cell apoptosis and oxidative stress. Importantly, lncRNA GAS5 attenuated EZH2 expression by recruiting E2F4 to the EZH2 promoter region and knockdown of EZH2 upregulated CDKN1C expression by inhibiting the H3K27me3.ConclusionThe evidence provided by our study highlighted the involvement of lncRNA GAS5 in the translational suppression of EZH2 as well as the upregulation of CDKN1C, resulting in the promotion of melanoma cell apoptosis and oxidative stress.

Highlights

  • The significance of long non-coding RNAs in mediating oxidative stress of cancers has been implicated recently

  • Expressed long non-coding RNAs (lncRNAs) growth arrest-specific transcript 5 (GAS5) in melanoma tissues and cells inhibits oxidative stress in melanoma To test whether the lncRNA GAS5 was dysregulated in melanoma cells, we performed reverse transcription quantitative polymerase chain reaction (RT-qPCR) assays for lncRNA GAS5 in 75 melanoma tissues and adjacent normal tissues from patients with melanoma

  • It was found that GAS5 was overexpressed in A375 cells while overexpression of lncRNA GAS5 attenuated the expression of enhancer of zeste homolog 2 (EZH2) and H3K27me3 and upregulated the expression of clin-dependent kinase inhibitor 1C (CDKN1C) (p < 0.05; Fig. 5e, f ) our results showed that lncRNA GAS5 did not regulate the E2F4 expression (p > 0.05; Fig. 5e, f )

Read more

Summary

Introduction

The significance of long non-coding RNAs (lncRNAs) in mediating oxidative stress of cancers has been implicated recently. This study proposed a potential therapeutic target lncRNA growth arrest-specific transcript 5 (GAS5) for melanoma, due to its crucial role in oxidative stress and apoptosis of melanoma cells by regulating the enhancer of zeste homolog 2 (EZH2)-mediated CDKN1C expression. The silencing of CDKN1C has been shown to contribute to the progression of colorectal carcinoma [18] Based on this above discussion, we hypothesized that lncRNA GAS5 acts as a suppressor in melanoma and its underlying mechanism could involve EZH2 and CDKN1C. This study was designed to further testify this hypothesis and to investigate the underlying regulatory molecular mechanism of lncRNA GAS5 in melanoma cell oxidative stress concerning EZH2 and CDKN1C, to present a theoretical foundation for an enhanced understanding of melanoma cancer progression

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call